Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Zoo Wildl Med ; 42(2): 322-5, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22946414

RESUMO

A 4.5-yr-old, captive-bred, male bearded dragon (Pogona vitticeps) presented for lethargy, anorexia, and increased mucoid salivation with upper respiratory clicks. Diagnostics were declined and the bearded dragon was prescribed ceftazidime 20 mg/kg i.m. q 72 hr. The patient presented again 1 wk later with a marked monocytosis, heterophilia, and lymphocytosis, and a clinical diagnosis of chronic monocytic leukemia was made. Chemotherapy with cytosine arabinoside (100 mg/m2 over 48 hr i.v.) was initiated. Forty-four hours into the treatment the dragon became acutely unresponsive and died within 1 hr. Adverse effects as a result of i.v. cytosine arabinoside therapy were not identified despite previous reports suggestive that the drug induces renal failure.


Assuntos
Antineoplásicos/uso terapêutico , Citarabina/uso terapêutico , Leucemia/veterinária , Lagartos , Animais , Antineoplásicos/administração & dosagem , Citarabina/administração & dosagem , Evolução Fatal , Leucemia/tratamento farmacológico , Masculino
2.
Vet Clin Pathol ; 36(1): 94-6, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17311202

RESUMO

A 1-year-old male Foxhound/Walker Hound mix was presented to the small animal internal medicine service at Louisiana State University School of Veterinary Medicine with a 6-week history of progressive, multifocal, ulcerative and draining, well-circumscribed lesions in a generalized distribution. Prior to referral, a presumptive diagnosis was made of sterile pyogranulomatous disease; immunosuppressive therapy was instituted but resulted in clinical deterioration. At presentation, the dog had marked neutropenia (1100 neutrophils/microL), and a mild toxic left shift (400 bands/microL). Cytologic findings in the exudates from a draining skin lesion included high numbers of markedly degenerate neutrophils (about 95% of nucleated cells) as well as low numbers of macrophages, small mature lymphocytes, and eosinophils. Low numbers of intracellular (within neutrophils and macrophages) and extracellular, pleomorphic, cigar-to-ovoid shaped organisms ( approximately 3x9 microm) consistent with Sporothrix were observed. Histopathologic examination of a skin biopsy showed marked, chronic, active, ulcerative, pyogranulomatous dermatitis and panniculitis, with intralesional yeast consistent with Sporothrix sp. The etiologic agent was confirmed as Sporothrix schenckii by macerated tissue fungal culture. The patient was treated with itraconazole, enrofloxacin, and clindamycin, with clinical resolution occurring over a 3-month period. This case is a rare example of the cytologic diagnosis of Sporothrix schenckii in a canine patient. Diagnosis of canine sporotrichosis is often challenging and usually requires tissue culture, as infected dogs typically harbor very few organisms. The patient's prior immunosuppressive therapy likely contributed to higher numbers of organisms in exudates from the cutaneous lesions, facilitating cytologic diagnosis.


Assuntos
Doenças do Cão/diagnóstico , Esporotricose/veterinária , Animais , Antibacterianos/uso terapêutico , Antifúngicos/uso terapêutico , Clindamicina/uso terapêutico , Doenças do Cão/tratamento farmacológico , Doenças do Cão/patologia , Cães , Enrofloxacina , Fluoroquinolonas/uso terapêutico , Itraconazol/uso terapêutico , Masculino , Esporotricose/diagnóstico , Esporotricose/tratamento farmacológico , Esporotricose/patologia
3.
Hum Gene Ther ; 15(9): 832-41, 2004 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-15353038

RESUMO

Despite extensive experience with recombinant adeno-associated virus (rAAV) 2 vectors in the lung, gene expression has been low in the context of cystic fibrosis (CF) gene therapy, where the large size of the cystic fibrosis transmembrane conductance regulator (CFTR) coding sequence has prompted the use of compact endogenous promoter elements. We evaluated the possibility that gene expression from recombinant adeno-associated virus (rAAV) could be improved by using alternate AAV capsid serotypes that target different cell-surface receptors (i.e., rAAV5) and/or using stronger promoters. The relative activities of the cytomegalovirus (CMV) Rous sarcoma virus (RSV) promoter, the CMV enhancer/beta-actin (CB) promoter combination, and the CMV enhancer/RSV promoter hybrid were assessed in vitro in a CF bronchial cell line. The CB promoter was the most efficient. AAV capsid serotypes, rAAV2 and rAAV5, were also compared, and rAAV5 was found to be significantly more efficient. Based on these studies a rAAV5-CB-promoter-driven CFTR minigene vector was then used to correct the CF chloride transport defect in vitro, as well as the hyperinflammatory lung phenotype in Pseudomonas-agarose bead challenged CF mouse lungs in vivo. These studies provide functional characterization of a new version of rAAV-CFTR vectors.


Assuntos
Regulador de Condutância Transmembrana em Fibrose Cística/genética , Fibrose Cística/terapia , Dependovirus/genética , Vetores Genéticos , Actinas/genética , Animais , Canais de Cloreto/efeitos dos fármacos , Clonagem Molecular , Fibrose Cística/genética , DNA Recombinante/uso terapêutico , Dependovirus/metabolismo , Expressão Gênica , Terapia Genética , Luciferases/análise , Luciferases/genética , Camundongos , Pneumonia/microbiologia , Pneumonia/patologia , Regiões Promotoras Genéticas , Pseudomonas aeruginosa/patogenicidade , Redução de Peso
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa